Meissa Vaccines develops live attenuated vaccine candidates against respiratory viruses, including respiratory syncytial virus (RSV) and COVID-19, using its proprietary AttenuBlock platform.

Meissa Vaccines

Pablo Air provides drone delivery solutions and UAM (Urban Air Mobility) integrated platform services, specializing in drone logistics and delivery systems.

Pablo Air

Meissa is involved in the manufacturing and sale of hospital equipment and furniture, focusing on medical products such as hospital beds, medical tables, and various hospital supplies. The company emphasizes quality and functionality in its offerings.

Meissa

Meissa Vaccines | 1,309 followers on LinkedIn. Taming Viruses with ​Synthetic Biology | Meissa is a private biotech company focused on the advancement of vaccines for respiratory viruses. Meissa was founded on proprietary technologies employing reverse genetics for rational design of more effective live attenuated vaccines. The technology is exclusively licensed from Emory University and Children’s Healthcare of Atlanta.

Metric
Company Name	Meissa Vaccines	Pablo Air	Meissa
Symbol
MSH ID	COM:MEISSAVACCINES	COM:PABLOAIR	TR:COM:MEISSA
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology	Healthcare & Health Services
Industry	Biotechnology	Aviation & Drone Technology	Medical Equipment Manufacturing
Country	US	KR	TR
Stage	Series A
Employee Count
Website	meissavaccines.com	pabloair.com	meissa.com.tr
LinkedIn	meissa-vaccines	pablo-air-co-ltd	meissa-medical-devices
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	995	2.42K
Web Traffic Growth	5.26	0.44
Valuation
Raised Capital	30M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

MEIS

COM:MEISSAVACCINES

Meissa Vaccines

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue